ACI
NNVC icon

Alpha Cubed Investments’s NanoViricides NNVC Stock Holding History

Alpha Cubed Investments’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,320
Closed -$6K – 265
2019
Q2 		$6K Buy
1,320
+660
+100% +$3.39K ﹤0.01% 256
2019
Q1 		$4K Buy
+660
New +$4.3K ﹤0.01% 244

Other funds holding NNVC

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return
BC
Bartlett & Co Cincinnati, Ohio $6.16B AUM 20.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Alpha Cubed Investments's NNVC Position: Q3 2019 in Review

Alpha Cubed Investments sold out of NanoViricides (NNVC) in Q3 2019, closing a stake of 1,320 shares — an estimated $6K sold.

Alpha Cubed Investments first reported a position in NNVC in Q1 2019 and held it in 2 quarters. The position peaked at $6K in Q2 2019. 17 funds tracked by Wall St. Rank hold NNVC as of Q3 2019.

  • Alpha Cubed Investments reported no remaining NanoViricides position as of Q3 2019 after selling out during the quarter.
  • Alpha Cubed Investments sold 1,320 NanoViricides shares in Q3 2019, an estimated $6K.
  • Alpha Cubed Investments first reported a position in NanoViricides in Q1 2019 and held it in 2 quarters.
  • Alpha Cubed Investments's NanoViricides position peaked at $6K in Q2 2019.
  • 17 funds tracked by Wall St. Rank held NanoViricides as of Q3 2019.

Based on Alpha Cubed Investments's 13F filing for Q3 2019, filed 18 Oct 2019.